Brain Edema XIII pp 125-129

The effect of intravenous fluid replacement on the response to mannitol in experimental cerebral edema: an analysis of intracranial pressure, serum osmolality, serum electrolytes, and brain water content

  • H. E. James
Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 96)


Albino rabbits that had undergone a cryogenic insult over the left parieto-occipital cortex were analyzed for serum osmolality, serum electrolytes, brain water content, and intracranial pressure (ICP) following either a baseline infusion of intravenous (IV) fluid (45 mL total) for 3 hours or above-maintenance isotonic saline (73.5 ± 12 mL or 90.5 ± 1.5 mL) and mannitol therapy. The subgroups were compared amongst themselves and to sham-operated controls. Serum osmolality was elevated in the higher-dose mannitol subgroup compared with maintenance IV fluids subgroup (1 g/kg/h vs 1 g/kg/3 h; p < 0.05), accompanied by an insignificant reduction of serum sodium. A significant reduction in brain water in the injured left hemisphere was seen following high-dose mannitol in the subgroup that received less IV (maintenance) fluids than the group that received above-maintenance IV fluids (p < 0.025). No reduction in brain water was seen in the subgroup that received above-maintenance IV fluids (non-treated groups). Reduction of ICP was not found in the lower mannitol dose group. We conclude that the ability of mannitol to reduce cerebral edema is related to the total amount of IV fluid replacement. This implies that the amount of IV crystalloid fluid that is administered to patients with cerebral edema and raised ICP requiring mannitol for control needs to be carefully monitored.


Edema mannitol osmolality intracranial pressure 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aviram A, Pfau A, Czaczkes JW, Ullmann TD (1967) Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol. Am J Med 42: 648–650PubMedCrossRefGoogle Scholar
  2. 2.
    Becker DP, Vries JK (1972) The alleviation of increased intracranial pressure by the chronic administration of osmotic agents. In: Brock M, Dietz H (eds) Intracranial Pressure. Springer-Verlag, New York, pp 310–315Google Scholar
  3. 3.
    Beks JW, ter Weeme CA (1967) The influence of urea and mannitol on increased intraventricular pressure in cold-induced cerebral edema. Acta Neurochir (Wien) 16: 97–107CrossRefGoogle Scholar
  4. 4.
    Bruce DA, Langfitt TW, Miller JD, Schutz H, Vapalahti MP, Stanek A, Goldberg HI (1973) Regional cerebral blood flow, intracranial pressure, and brain metabolism in comatose patients. J Neurosurg 38: 131–144PubMedGoogle Scholar
  5. 5.
    Buhrley LE, Reed DJ (1972) The effect of furosemide on sodium-22 uptake into the cerebrospinal fluid and brain. Exp Brain Res 14: 503–510PubMedCrossRefGoogle Scholar
  6. 6.
    Goluboff B, Shenkin HA, Haft H (1964) The effect of mannitol and urea on cerebral hemodynamics and cerebrospinal fluid pressure. Neurology 14: 891–898PubMedGoogle Scholar
  7. 7.
    Herrmann HD, Neuenfeldt D (1972) Development and regression of a disturbance of the blood-brain barrier and of edema in tissue surrounding a circumscribed cold lesion. Exp Neurol 34: 115–120PubMedCrossRefGoogle Scholar
  8. 8.
    Javid M, Anderson J (1959) The effect of urea on cerebrospinal fluid pressure in monkeys before and after bilateral nephrectomy. J Lab Clin Med 53: 484–489PubMedGoogle Scholar
  9. 9.
    James HE, Langfitt TW, Kumar VS, Ghostine SY (1977) Treatment of intracranial hypertension: analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir (Wien) 36: 189–200CrossRefGoogle Scholar
  10. 10.
    James HE, Bruce DA, Welsh F (1978) Cytotoxic edema produced by 6-aminonicotinamide and its response to therapy. Neurosurgery 3: 196–200PubMedGoogle Scholar
  11. 11.
    James HE (1980) Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien) 51: 161–172CrossRefGoogle Scholar
  12. 12.
    James HE, Schneider S (1993) Effects of acute isotonic saline administration on serum osmolality, serum electrolytes, brain water content and intracranial pressure. Acta Neurochir [Suppl] 57: 89–93Google Scholar
  13. 13.
    Javid M, Gilboe D, Cesario T (1964) The rebound phenomenon and hypertonic solutions. J Neurosurg 21: 1059–1066PubMedGoogle Scholar
  14. 14.
    Langfitt TW (1961) Possible mechanisms of action of hypertonic urea in reducing intracranial pressure. Neurology 11: 196–209PubMedGoogle Scholar
  15. 15.
    Leech P, Miller JD (1974) Intracranial volume-pressure relationships during experimental brain compression in primates. 3. Effects of mannitol and hyperventilation. J Neurol Neurosurg Psychiatry 37: 1105–1111PubMedCrossRefGoogle Scholar
  16. 16.
    Marshall LF, Smith RW, Rauscher LA, Shapiro HM (1978) Mannitol dose requirements in brain-injured patients. J Neurosurg 48: 169–172PubMedGoogle Scholar
  17. 17.
    Miller JD, Leech P (1975) Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients. J Neurosurg 42: 274–281PubMedCrossRefGoogle Scholar
  18. 18.
    Pappius HM, Dayes LA (1965) Hypertonic urea. Its effect on the distribution of water and electrolytes in normal and edematous brain tissue. Arch Neurol 13: 395–402PubMedGoogle Scholar
  19. 19.
    Pollay M, Fullenwider C, Roberts PA, Stevens FA (1983) Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 59: 945–950PubMedGoogle Scholar
  20. 20.
    Prill A, Volles E, Dahlmann W (1972) Stabilization and disturbance of osmoregulation in the cerebrospinal fluid. In: Brock M, Dietz H (eds) Intracranial pressure. Springer Berlin Heidelberg New York Tokyo, pp 303–308Google Scholar
  21. 21.
    Szewczykowski J, Sliwka S, Kunicki A, Korsack-Sliwka J, Dziduszko J, Dytko P, Augustyniak B (1975) Computer-assisted analysis of intraventricular pressure after mannitol administration. J Neurosurg 43: 136–141PubMedGoogle Scholar
  22. 22.
    Shenkin HA, Goluboff B, Haft H (1962) The use of mannitol for the reduction of intracranial pressure in intracranial surgery. J Neurosurg 19: 897–901PubMedGoogle Scholar
  23. 23.
    Shenkin HA, Bexier HS, Bouzarth WF (1976) Restricted fluid intake. Rational management of the neurosurgical patient. J Neurosurg 45: 432–436PubMedGoogle Scholar
  24. 24.
    Silber SJ, Thompson N (1972) Mannitol induced central nervous system toxicity in renal failure. Invest Urol 9: 310–312PubMedGoogle Scholar
  25. 25.
    Stuart FP, Torres E, Fletcher D, Moore FD (1970) Effects of single, repeated and massive mannitol infusion in the dog: structural and functional changes to the kidney and brain. Ann Surg 172: 190–204PubMedGoogle Scholar
  26. 26.
    Troupp H, Valtonen S, Vapalahti M (1971) Intraventricular pressure after administration of dehydrating agents to severely brain injured patients: is there a rebound phenomenon? Acta Neurochir (Wien) 24: 89–95CrossRefGoogle Scholar
  27. 27.
    Wise BL, Chater N (1962) The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 19: 1038–1043PubMedGoogle Scholar
  28. 28.
    Wise BL (1963) Effects of infusion of hypertonic mannitol on electrolyte balance and on osmolarity of serum and cerebrospinal fluid. J Neurosurg 20: 961–996PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • H. E. James
    • 2
    • 3
    • 1
  1. 1.Lucy Gooding Pediatric Neurosurgery CenterUniversity of Florida HSC/JacksonvilleJacksonvilleUSA
  2. 2.University of Florida Jacksonville and Wolfson Children’s HospitalJacksonville
  3. 3.University of California San DiegoSan DiegoUSA

Personalised recommendations